Tech & Health

Team finds drug repurposing signal in e-health records

With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have any hidden therapeutic benefits that could warrant putting additional indications on the label and increasing production.

Cox to lead trans-institutional genetics efforts

Nancy J. Cox, Ph.D., professor of Medicine and Human Genetics and chief of the Section of Genetic Medicine at the University of Chicago, has been appointed founding director of a new genetics institute at Vanderbilt University, effective Jan. 1, 2015.

hamburger and fries

Vanderbilt study supports notion ‘You are what you eat’

An international research group led by Vanderbilt University scientists has shown for the first time that a lipid, or fat molecule, can regulate “psychostimulant” behaviors by interacting with a brain protein.

Informatics tools link protein structure, drug action: speaker

Russ Altman, M.D., Ph.D., professor of Bioengineering, Genetics and Medicine at Stanford University, posed an intriguing question at last week’s Discovery Lecture: is it possible to predict drug side effects from the 3D-structure of proteins?

Proton transfer powers multidrug resistance: study

Vanderbilt University researchers and their Belgian colleagues have discovered the mechanism behind a multidrug transporter. Their findings, posted this week by Nature Chemical Biology, could lead to new treatments for multidrug resistant bacterial infections.

Norman named dean of School of Nursing

Linda Norman, DSN, R.N., who for 22 years has spearheaded curricular innovations at Vanderbilt University School of Nursing (VUSN), will become the school’s new dean pending Board of Trust approval, effective July 1.

1 13 14 15 16 17